A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis
Publication
, Journal Article
Chung, MP; Valenzuela, A; Li, S; Catanese, B; Stevens, K; Fiorentino, D; Strand, V; Chung, L
Published in: Rheumatology
May 30, 2022
Duke Scholars
Published In
Rheumatology
DOI
EISSN
1462-0332
ISSN
1462-0324
Publication Date
May 30, 2022
Volume
61
Issue
6
Start / End Page
2441 / 2449
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Chung, M. P., Valenzuela, A., Li, S., Catanese, B., Stevens, K., Fiorentino, D., … Chung, L. (2022). A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis. Rheumatology, 61(6), 2441–2449. https://doi.org/10.1093/rheumatology/keab810
Chung, Melody P., Antonia Valenzuela, Shufeng Li, Benjamin Catanese, Kate Stevens, David Fiorentino, Vibeke Strand, and Lorinda Chung. “A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis.” Rheumatology 61, no. 6 (May 30, 2022): 2441–49. https://doi.org/10.1093/rheumatology/keab810.
Chung MP, Valenzuela A, Li S, Catanese B, Stevens K, Fiorentino D, et al. A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis. Rheumatology. 2022 May 30;61(6):2441–9.
Chung, Melody P., et al. “A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis.” Rheumatology, vol. 61, no. 6, Oxford University Press (OUP), May 2022, pp. 2441–49. Crossref, doi:10.1093/rheumatology/keab810.
Chung MP, Valenzuela A, Li S, Catanese B, Stevens K, Fiorentino D, Strand V, Chung L. A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis. Rheumatology. Oxford University Press (OUP); 2022 May 30;61(6):2441–2449.
Published In
Rheumatology
DOI
EISSN
1462-0332
ISSN
1462-0324
Publication Date
May 30, 2022
Volume
61
Issue
6
Start / End Page
2441 / 2449
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences